Nadia Lybøl von Schoubye, Ph.D.
Affiliations: | 2022- | CNS Diseases | Boehringer Ingelheim Pharma GmbH & Co. KG |
Area:
CNS Drug DiscoveryGoogle:
"Nadia von Schoubye"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Thomas Jespersen | grad student | Copenhagen University | |
| Uffe Kristiansen | grad student | Copenhagen University | |
| Jean-Francois Perrier | grad student | Copenhagen University | |
| Palle Christophersen | research scientist | 2016-2022 | Saniona A/S |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| von Schoubye NL, Frederiksen K, Kristiansen U, et al. (2017) The sodium channel activator Lu AE98134 normalizes the altered firing properties of fast spiking interneurons in Dlx5/6(+/-) mice. Neuroscience Letters |
| Simonsen C, Boddum K, von Schoubye NL, et al. (2017) Anticonvulsive evaluation of THIP in the murine pentylenetetrazole kindling model: lack of anticonvulsive effect of THIP despite functional δ-subunit-containing GABAA receptors in dentate gyrus granule cells. Pharmacology Research & Perspectives. 5 |
| Boddum K, Hougaard C, Xiao-Ying Lin J, et al. (2017) Kv3.1/Kv3.2 channel positive modulators enable faster activating kinetics and increase firing frequency in fast-spiking GABAergic interneurons. Neuropharmacology. 118: 102-112 |
| Taskin B, von Schoubye NL, Sheykhzade M, et al. (2015) Biophysical characterization of KV3.1 potassium channel activating compounds. European Journal of Pharmacology. 758: 164-70 |